Navigation Links
Pharmos Corporation Reports 2008 First Quarter Results
Date:5/8/2008

ISELIN, N.J., May 8 /PRNewswire-FirstCall/ -- Pharmos Corporation (Nasdaq: PARS) today reported results for the first quarter ended March 31, 2008. The Company recorded a net loss of $3.6 million, or $0.14 per share, for the first quarter 2008 compared to a net loss of $4.8 million, or $0.19 per share, in the first quarter 2007. Cash and short-term investments totaled $11.3 million at March 31, 2008.

The decrease in net loss for the first quarter 2008 is due primarily to a 29% decrease in operating expenses, which was driven by a 68% decrease in general and administrative expenses to $0.8 million compared to $2.5 million in the first quarter 2007.

Research & development net, increased by $208,136 or 8%, from $2,570,098 in 2007 to $2,778,234 in 2008. Increased expenditures for the dextofisopam clinical trial are offset in part by the cost savings resulting from the downsizing and curtailment of general R&D programs. CB2 research and discovery and R&D overhead at our Rehovot facility were the areas of reduced spending.

During the first quarter, the Company advanced a Phase IIb trial of its lead compound, dextofisopam, in female IBS patients, which is expected to enroll approximately 480 patients in about 70 sites over an 18 month period. Costs of $2.0 million were incurred during the quarter in connection with the trial, comprising CRO-related activities and patient recruitment costs. Dextofisopam was one of the compounds the Company obtained through the acquisition of Vela Pharmaceuticals Inc. which closed in October 2006. The continued development of this compound through late-stage clinical testing will significantly increase the research and development expenses going forward.

A Phase 2a clinical trial with t
'/>"/>

SOURCE Pharmos Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Pharmos Issues Letter to Shareholders
2. Pharmos Corporation Reports 2007 Third Quarter Results
3. Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference
4. Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
5. Pharmos Corporation Announces Board and Management Changes
6. Pharmos Corporation Completes Initial Closing of Private Placement
7. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. BioElectronics Corporation Announces Singapore and Malaysia Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...ctober 13 /- Mentice, a leading,suppl... the appointment of,Mr. Bjorn Larsson as Vice Pres...Mr. Bjorn Larsson will head up and coordinate,Ment...te standpoint., Mr. Larsson brings to Mentice ove...g and product management within pharmaceuticals an...
(Date:10/13/2008)...3 /- Thursday and Friday of...cientific,s (NYSE: BSX ),stock. As anticipated in...cant portion of this trading was due to involuntar...entific,s co-founders Pete Nicholas and,John Abele...mately 31,million shares in aggregate had been sol...
(Date:10/13/2008)... In March 2007, Joe Weitz left his position of 15 ...es to Go/Lastar Inc. to form American Consumer Cab...ates Air Force veterans he partners with at Americ...ne providers of technology-based connectivity solu...nectivity product solutions including audio cables...
(Date:10/12/2008)...ewswire-FirstCall/ -- Cell Therapeutics, Inc.,(CTI...ent at three upcoming,investor conferences. The co...m in San Francisco in October, the 19th Annual Opp...Annual Acumen BioFin Rodman & Renshaw,Healthcare C...e presentations will be webcast live with slides, ...
Breaking Biology Technology:Mentice Appoints Bjorn Larsson as Vice President of Global Marketing 2Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders 2Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders 3 Former Cables to Go/Lastar Inc. Employee's Move to Form American Consumer Cables Pays Off 2Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences 2
...semiconductor techniques invented by University o...ing, computing, and imaging capability to an amazi...onductor industry has relied on flat, two-dimensio...ms of material that become electronic circuits for...in as those chips might seem, they are quite beefy...
... molecular diagnostics and drug discovery is expan...l distribution capability of Prodesse, Inc. , a b...license agreement, Prodesse will add to its offeri...tension (LUX) technology from the Carlsbad, Calif....r of multiplex polymerase chain-reaction technolog...
...announcement of increased quarterly revenues, Son...logy, once again projected cash flow break even fo...tability projected for 2007. , ,Chairman and CEO R... results for Sonic Foundry,s 2006 third quarter in... synchronized web presentation system, Mediasite. ...
...s Air Force contract to fund the development of sm...e a Madison aerospace research and product develop...enable it to propel something much larger. , ,The ...3.9 million to Orbital Technologies Corp. (Orbit... but it might issue additional delivery orders dep...
Other Biology Technology:UW produces fast and flexible computer chip 2Prodesse joins forces with Invitrogen 2Sonic closer to turning profit corner 2Sonic closer to turning profit corner 3Sonic closer to turning profit corner 4Orbitec will use $25 million Air Force contract to make small launch vehicle 2
(Date:10/13/2008)...lled the "Evaluate the Clinical use of vitamin K S...enia" (ECKO) trial, Angela Cheung and colleagues a... daily vitamin K1 supplement did not protect again... However, as reported in this week,s PLoS Medicin...protect against fracture and cancer in postmenopau...
(Date:10/13/2008)...atients had insufficient levels of vitamin D in a .... , The fraction of Parkinson,s patients with v...tly more than patients with Alzheimer,s disease (4... , The results are published in the October issu... to evidence that low vitamin D is associated with...
(Date:10/13/2008)...mbryonic mouse heart has an astounding capacity to... in non-mammalian species. The research, published...urnal Developmental Cell , describes the previous...o replace diseased tissue through compensatory pro...mitochondria, a cell structure required for energy...
(Date:10/12/2008)... French . , Researchers at McGill University,...ve identified two genetic variants in caucasians t...ase the risk of male pattern baldness. Their resul...e Genetics. , About a third of all men are affe...tion,s social and economic impact is considerable:...
Breaking Biology News(10 mins):Lack of vitamin D linked to Parkinson's disease 2Lack of vitamin D linked to Parkinson's disease 3Embryonic heart exhibits impressive regenerative capacity 2Researchers discover baldness gene: 1 in 7 men at risk 2Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves 16189 1Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves 16189 2Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves 16189 3Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves 16189 4Revolutionary CO2 maps zoom in on greenhouse gas sources 2797 1Revolutionary CO2 maps zoom in on greenhouse gas sources 2797 2Revolutionary CO2 maps zoom in on greenhouse gas sources 2797 3Revolutionary CO2 maps zoom in on greenhouse gas sources 2797 4Revolutionary CO2 maps zoom in on greenhouse gas sources 2797 5Consumer Reports 3A If Your Gums Could Speak 16180 1Consumer Reports 3A If Your Gums Could Speak 16180 2The PA Breast Cancer Coalition Participates in 2008 Patient Advocacy Leaders Summit 28PALS 29 3A PALs 28Patient Advocacy Leaders 29 for a Healthier 16175 1The PA Breast Cancer Coalition Participates in 2008 Patient Advocacy Leaders Summit 28PALS 29 3A PALs 28Patient Advocacy Leaders 29 for a Healthier 16175 2
...ject with implications,for malaria vaccine develop...d gene expression studies to trace how malaria par...tween their hosts and insect,vectors.,That focus o...earchers,understand when different genes switch on...en different life stages. In turn, that,molecular-...
...birds accustomed to nesting on islands free of pre... introducing foxes onto islands in the Aleutian ar...birds made easy meals for the foxes. A study publi...at the effects of the introduced foxes rippled thr...getation from lush grasslands to scrubby, low-grow...
...st week reveal how an,evolutionary innovation invo... has given rise to a deep-seated dependency betwee...s.,The new work illustrates how genetic exchange t...rise to a system of interdependence at a,high leve...roduction of,worker ants for both species. , Milli...
...ractions between flowers and their pollinators hav...n order to entice pollinators such as bees, flies ... their flowers, plants have evolved intriguing mec...nown. , Thirty years ago, researchers discovered ...contain substantial amounts of amino acids. Recent...
Other Biology News:Scientists reveal molecular secrets of the malaria parasite 2Scientists reveal molecular secrets of the malaria parasite 3Introduced foxes transformed vegetation on Aleutian Islands from lush grasslands to tundra 2Introduced foxes transformed vegetation on Aleutian Islands from lush grasslands to tundra 3Introduced foxes transformed vegetation on Aleutian Islands from lush grasslands to tundra 4Ants Genetic Engineering Leads To Species Interdependency 2
Sterile, individually wrapped, 4mm Cuvettes
...an enhanced form of Tobacco Etch Virus (TEV) prote...nd significantly more stable than native TEV prote...se specifically recognizes a seven amino acid (Glu... Gly), making it useful for removing affinity tags...
... a fully flexible quadrupole MS detector optimized...peed HPLC, 1-D and 2-D LC, as well as capillary an... gas system to create a finer spray mist for high ... compounds, while providing for high reliability, ...
S-100A10 (H-80)
Biology Products: